Insulin icodec clinical trials
Also written Insulin 287.
How each study uses insulin icodec is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the insulin icodec studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 Mar 2026 · AWIQLI FLEXTOUCH · BLA 761326 (FDA, Drugs@FDA)
- European Union
- 17 May 2024 · Awiqli · EMEA/H/C/005978 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
30 studies that test it; most in 2021 (6); 1 more planned to start later
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 30 · Other 1
Novo Nordisk A/S (30) · Xi'an International Medical Center Hospital (1)
Often tested with
Tested in the same studies.
Semaglutide (2) · Insulin Glargine (1) · Insulin degludec (1) · NNC0148 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Insulin icodec is the comparator. A study of two new drugs counts under both.
- 1GZR4 · Gan & Lee Pharmaceuticals. · next primary completion Nov 2026
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test insulin icodec, phase 3 first.
- Jan 2027A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesPhase 3 · Novo Nordisk A/S
- Oct 2027Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 DiabetesPhase 4 · Xi'an International Medical Center Hospital
Studies
Open first, then newest update. How each study uses insulin icodec is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 31
- A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesRecruitingPhase 4Novo Nordisk A/SNCT07112339Written as Insulin icodec
- Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 DiabetesNot yet recruitingPhase 4Xi'an International Medical Center HospitalNCT07747402Written as Insulin icodec
- A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesActive, not recruitingPhase 3Novo Nordisk A/SNCT07076199Written as Insulin icodec
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedPhase 3Novo Nordisk A/SNCT04760626Written as Insulin icodec
- A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT06340854Written as Insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)CompletedPhase 3Novo Nordisk A/SNCT04795531Written as Insulin icodec
- A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingCompletedPhase 1Novo Nordisk A/SNCT06288412Written as Insulin icodec
- A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT05813912Written as Insulin Icodec
- A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)CompletedPhase 3Novo Nordisk A/SNCT05823948Written as Insulin Icodec
- A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and TeenagersCompletedPhase 1Novo Nordisk A/SNCT05790681Written as Insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinCompletedPhase 3Novo Nordisk A/SNCT04770532Written as Insulin Icodec
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)CompletedPhase 3Novo Nordisk A/SNCT04848480Written as insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)CompletedPhase 3Novo Nordisk A/SNCT04880850Written as Insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedPhase 3Novo Nordisk A/SNCT04460885Written as Insulin icodec
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecCompletedPhase 3Novo Nordisk A/SNCT05352815Written as IcoSema
- A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCompletedPhase 1Novo Nordisk A/SNCT05435677Written as IcoSema
- A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a WeekCompletedPhase 1Novo Nordisk A/SNCT03723772Written as Insulin icodec
- A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or TogetherCompletedPhase 1Novo Nordisk A/SNCT03789578Written as NNC0148-0287
- A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney ProblemsCompletedPhase 1Novo Nordisk A/SNCT03723785Written as Insulin icodec
- A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People With Liver DiseaseCompletedPhase 1Novo Nordisk A/SNCT04597697Written as Insulin icodec
See all 31 studies that test insulin icodec →
Given beside what is tested · 4 — insulin icodec is usual care or a partner of the new treatment
- Clinical Trials of IBI3035 in Healthy SubjectsRecruitingPhase 1Innovent Biologics (Suzhou) Co. Ltd.NCT07591519Written as Insulin icodec Injection
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)CompletedPhase 3Novo Nordisk A/SNCT05259033Written as IcoSema
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)CompletedPhase 3Novo Nordisk A/SNCT06269107Written as IcoSema
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedPhase 3Novo Nordisk A/SNCT05013229Written as IcoSema
As the comparator · 2 — what is tested is compared with insulin icodec
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult MalesRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07630233Written as Insulin Icodec Injection
- A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinRecruitingPhase 3Gan & Lee Pharmaceuticals.NCT07165223Written as Insulin Icodec group
Codes
What other systems call insulin icodec · ClinicalTrials.gg INT001500
- MeSH (NLM) C000712207insulin icodecConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) P7YU3ED05NINSULIN ICODECConfirmed FDA, NLM, Wikidata
- Wikidata Q111982305insulin icodecConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C175800Insulin IcodecOne source FDA
- DrugBank DB16693One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000712207 | insulin icodec | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | P7YU3ED05N | INSULIN ICODEC | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q111982305 | insulin icodec | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C175800 | Insulin Icodec | One source FDA |
| DrugBank | DB16693 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.